Pulmonx Pre-Tax Profit Margin 2019-2025 | LUNG
Pulmonx pre-tax profit margin from 2019 to 2025. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue.
| Pulmonx Pre-Tax Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Pre-Tax Income | Pre-Tax Margin |
| 2025-03-31 | $0.09B | $-0.06B | -63.64% |
| 2024-12-31 | $0.08B | $-0.06B | -66.67% |
| 2024-09-30 | $0.08B | $-0.06B | -72.15% |
| 2024-06-30 | $0.08B | $-0.06B | -75.32% |
| 2024-03-31 | $0.07B | $-0.06B | -80.82% |
| 2023-12-31 | $0.07B | $-0.06B | -88.41% |
| 2023-09-30 | $0.07B | $-0.06B | -93.85% |
| 2023-06-30 | $0.06B | $-0.06B | -98.36% |
| 2023-03-31 | $0.06B | $-0.06B | -101.72% |
| 2022-12-31 | $0.05B | $-0.06B | -109.26% |
| 2022-09-30 | $0.05B | $-0.06B | -109.43% |
| 2022-06-30 | $0.05B | $-0.05B | -103.85% |
| 2022-03-31 | $0.05B | $-0.05B | -104.00% |
| 2021-12-31 | $0.05B | $-0.05B | -100.00% |
| 2021-09-30 | $0.04B | $-0.04B | -100.00% |
| 2021-06-30 | $0.04B | $-0.04B | -90.48% |
| 2021-03-31 | $0.03B | $-0.04B | -108.82% |
| 2020-12-31 | $0.03B | $-0.03B | -94.12% |
| 2020-06-30 | $0.02B | $-0.02B | -104.55% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.104B | $0.084B |
| Pulmonx Corporation is a medical technology company. It designs, develops, manufactures and markets minimally invasive medical devices for the diagnosis and treatment of chronic obstructive pulmonary diseases. Pulmonx Corporation is based in Redwood City, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $45.950B | 58.46 |
| Tempus AI (TEM) | United States | $11.831B | 0.00 |
| Doximity (DOCS) | United States | $11.347B | 52.53 |
| Hims & Hers Health (HIMS) | United States | $10.359B | 107.63 |
| IRhythm Technologies (IRTC) | United States | $4.875B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $3.826B | 59.77 |
| Hinge Health (HNGE) | United States | $3.508B | 0.00 |
| Privia Health (PRVA) | United States | $2.682B | 183.33 |
| Enovis (ENOV) | United States | $1.843B | 10.27 |
| Phreesia (PHR) | United States | $1.663B | 0.00 |
| Schrodinger (SDGR) | United States | $1.503B | 0.00 |
| 10x Genomics (TXG) | United States | $1.441B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.420B | 0.00 |
| Azenta (AZTA) | United States | $1.409B | 65.47 |
| Omnicell (OMCL) | United States | $1.351B | 23.83 |
| Evolent Health (EVH) | United States | $1.262B | 107.50 |
| Claritev (CTEV) | United States | $0.703B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.597B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.500B | 0.00 |
| Veradigm (MDRX) | United States | $0.487B | 0.00 |
| Standard BioTools (LAB) | United States | $0.482B | 0.00 |
| Talkspace (TALK) | United States | $0.460B | 137.50 |
| Outset Medical (OM) | United States | $0.357B | 0.00 |
| TruBridge (TBRG) | United States | $0.355B | 787.33 |
| Nyxoah SA (NYXH) | Belgium | $0.262B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.261B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.207B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.165B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.133B | 0.00 |
| American Well (AMWL) | United States | $0.118B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.103B | 0.00 |
| CareCloud (CCLD) | United States | $0.096B | 3.68 |
| 111 (YI) | China | $0.064B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.051B | 0.00 |
| HeartBeam (BEAT) | United States | $0.047B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.044B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.039B | 0.00 |
| Zhongchao (ZCMD) | China | $0.031B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.023B | 0.00 |
| Precipio (PRPO) | United States | $0.017B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.015B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.011B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.010B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.010B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.008B | 0.00 |
| Movano (MOVE) | United States | $0.005B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.003B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |